Accurate Diagnosis and Effective Management of Children with Growth Hormone Deficiency: What Can You Do to Improve Patient Outcomes in Your Clinical Practice?

FACULTY

Andrew Dauber, MD, MMSc
Chief of Endocrinology
Children’s National Hospital
Washington, DC

PROGRAM OVERVIEW

This case-based online activity will be designed to increase the ability of US-based endocrinologists, endocrine fellows, primary care physicians, physician assistants, nurse practitioners, and healthcare professionals to utilize diagnostic assays and overall clinical evaluations to achieve a timely diagnosis of children with growth hormone deficiency (CGHD). In practice; recognize the efficacy and safety profiles associated with recombinant human GH therapy for CGHD. Upon approval, integrate LAGH preparations for use in the long-term treatment of CGHD, individualizing dosing and monitoring patients; and foster the continued care of patients with CGHD to adult care.

TARGET AUDIENCE

This activity is intended to meet the educational needs of US-based endocrinologists, endocrine fellows, primary care physicians, physician assistants, nurse practitioners, and healthcare professionals who diagnose and manage children with growth hormone deficiency (CGHD).

LEARNING OBJECTIVES

• Evaluate CGHD screening and diagnostic strategies including appropriate tests and key elements of a differential diagnosis
• Interpret data on the clinical profiles of and adherence rates to standard of care therapies for CGHD
• Assess data from clinical trials of novel LAGH preparations that may be used for the long‐term management of CGHD, pending their approval
• Design individualized strategies aimed at providing effective long‐term management of CGHD for those treated with LAGH preparations, pending approval
• Facilitate the transition of patients with CGHD to adult care

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in diagnosing and managing children with growth hormone deficiency.

CNE Credits: 1.0 ANCC Contact Hour.

AAFP STATEMENT

The AAFP has reviewed Accurate Diagnosis and Effective Management of Children with Growth Hormone Deficiency: What Can You Do to Improve Patient Outcomes in Your Clinical Practice? and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval is from 01/20/2022 to 01/20/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA/AAFP Equivalency

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturers of any commercial products and/or providers of commercial services that are discussed in an educational activity.

Andrew Dauber, MD has received research support from BioMarin Pharmaceutical, Pfizer, Novo Nordisk, and Ipsen; he has served as a consultant for BioMarin, Novo Nordisk, Ascendis Pharma, Ipsen, Sandoz, and OPKO Health.

CME Content Review

The content of this activity was independently peer-reviewed.

The reviewer of this activity has nothing to disclose.

CNE Content Review

The content of this activity was peer-reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN

Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
Angela Davis, Medical Director of Med Learning Group, has nothing to disclose.
Ana Maria Albino, Senior Program Manager of Med Learning Group, has nothing to disclose.
Jessica Feygin, Program Coordinator of Med Learning Group, has nothing to disclose.
Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
Daniel Dasilva, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME/CE credit for this online activity. To receive CME/CE credit participants must:

1. Read the CME/CNE information and faculty disclosures.
2. Participate in the online activity.
3. Submit the evaluation form to Med Learning Group.

You will receive your certificate upon completion as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.